MOGAD pathophysiology informs some of the relatively unique clinical and radiologic
features which have come to define this condition, and similarly has implications for …

COVID‐19 has had a significant impact on the global population and has produced
compelling evidence of non‐pulmonary organ dysfunction, including the nervous system. It …

SARS-CoV-2 can trigger autoimmune central nervous system (CNS) diseases in genetically
susceptible individuals, a mechanism poorly understood. Molecular mimicry (MM) has been …

Background Many neurologic complications have been described after severe acute
respiratory syndrome Coronavirus-2 (SARS-CoV-2) including atypical cases of optic neuritis …

Introduction Since the beginning, there has been enough evidence about the multi-
systematic involvement of the coronavirus disease 2019 (COVID-19), which is caused by …

The first formal consensus diagnostic criteria for myelin oligodendrocyte glycoprotein
antibody-associated disease (MOGAD) were recently proposed. Yet, the distinction of …

Recent reports indicated that myelin oligodendrocyte glycoprotein antibody-associated
disease might be a rare complication after severe acute respiratory syndrome coronavirus 2 …

Background Anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibody-associated
disease (MOGAD) is an immune-mediated neurological disorder with a broad spectrum of …

Background New neurological complications of COVID-19 infection have been reported in
recent research. Among them, the spectrum of anti-MOG positive diseases, defined as anti …

Background This study aims to characterise the symptoms and clinical features of optic
neuritis (ON) following SARS-CoV-2 infection and vaccination. Method A literature search …